Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Melioli

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemiaL Del Mastro, M Venturini, R Lionetto, et al.
European Annals of Allergy and Clinical Immunology|April 18, 2014
Molecular diagnosis and the Italian Board for ISACE Nettis, F Bonifazi, S Bonini, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 5, 2011
Burden of rotavirus infections in Liguria, Northern Italy: hospitalisations and potential savings by vaccinationD Panatto, D Amicizia, R Giacchino, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|May 16, 2012
Serum insulin-like growth factor-I (IGF-I) reference ranges for chemiluminescence assay in childhood and adolescence. Data from a population of in- and out-patientsG Bedogni, G Giannone, M Maghnie, et al.
Oncology Reports|May 19, 2011
Analysis of the proliferative and phenotypic properties of tumor infiltrating lymphocytes expanded in vitro in the course of the clinical trial of adoptive immunotherapy of metastatic melanomaG Pietra, C Semino, S Basso, et al.
Allergy|July 30, 2013
The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergyG Passalacqua, G Melioli, F Bonifazi, et al.
Annals of Surgical Oncology|May 26, 1999
Adoptive immunotherapy with tumor-infiltrating lymphocytes and subcutaneous recombinant interleukin-2 plus interferon alfa-2a for melanoma patients with nonresectable distant disease: a phase I/II pilot trial. Melanoma Istituto Scientifico Tumori GroupP Queirolo, M Ponte, M Gipponi, et al.
International Journal of Cancer|February 15, 1989
Phenotypic and functional characteristics of tumor-associated lymphocytes in patients with malignant ascites receiving intraperitoneal infusions of recombinant interleukin-2 (rIL-2)G Melioli, E Baldini, M C Mingari, et al.
Anticancer Research|March 4, 2000
Adoptive immunotherapy of advanced solid tumors: an eight year clinical experienceC Semino, L Martini, P Queirolo, et al.
European Review for Medical and Pharmacological Sciences|September 22, 2016
The involvement of IgH enhancer HS1.2 in the pathogenesis of Crohn's disease: how the immune system can influence a multifactorial diseaseR Cianci, S Lolli, D Pagliari, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemiaL Del Mastro, M Venturini, R Lionetto, et al.
European Annals of Allergy and Clinical Immunology|April 18, 2014
Molecular diagnosis and the Italian Board for ISACE Nettis, F Bonifazi, S Bonini, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 5, 2011
Burden of rotavirus infections in Liguria, Northern Italy: hospitalisations and potential savings by vaccinationD Panatto, D Amicizia, R Giacchino, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|May 16, 2012
Serum insulin-like growth factor-I (IGF-I) reference ranges for chemiluminescence assay in childhood and adolescence. Data from a population of in- and out-patientsG Bedogni, G Giannone, M Maghnie, et al.
Oncology Reports|May 19, 2011
Analysis of the proliferative and phenotypic properties of tumor infiltrating lymphocytes expanded in vitro in the course of the clinical trial of adoptive immunotherapy of metastatic melanomaG Pietra, C Semino, S Basso, et al.
Allergy|July 30, 2013
The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergyG Passalacqua, G Melioli, F Bonifazi, et al.
Annals of Surgical Oncology|May 26, 1999
Adoptive immunotherapy with tumor-infiltrating lymphocytes and subcutaneous recombinant interleukin-2 plus interferon alfa-2a for melanoma patients with nonresectable distant disease: a phase I/II pilot trial. Melanoma Istituto Scientifico Tumori GroupP Queirolo, M Ponte, M Gipponi, et al.
International Journal of Cancer|February 15, 1989
Phenotypic and functional characteristics of tumor-associated lymphocytes in patients with malignant ascites receiving intraperitoneal infusions of recombinant interleukin-2 (rIL-2)G Melioli, E Baldini, M C Mingari, et al.
Anticancer Research|March 4, 2000
Adoptive immunotherapy of advanced solid tumors: an eight year clinical experienceC Semino, L Martini, P Queirolo, et al.
European Review for Medical and Pharmacological Sciences|September 22, 2016
The involvement of IgH enhancer HS1.2 in the pathogenesis of Crohn's disease: how the immune system can influence a multifactorial diseaseR Cianci, S Lolli, D Pagliari, et al.
Pageof 12